Mainz, Germany

Michael Erdeljan

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 8.5

ph-index = 3

Forward Citations = 39(Granted Patents)


Location History:

  • Hochheim am Main, DE (2016 - 2024)
  • Mainz, DE (2016 - 2024)

Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Michael Erdeljan: Innovator in Cancer Therapeutics

Introduction

Michael Erdeljan is a prominent inventor based in Mainz, Germany. He has made significant contributions to the field of cancer therapeutics, holding a total of eight patents. His work focuses on developing innovative solutions for treating various types of cancer.

Latest Patents

Among his latest patents are antibodies specific for claudin 6 (CLDN6). These antibodies are designed to be therapeutics for treating and preventing diseases associated with cells that express CLDN6. This includes a wide range of tumor-related diseases such as ovarian cancer, lung cancer, gastric cancer, breast cancer, hepatic cancer, pancreatic cancer, skin cancer, malignant melanoma, head and neck cancer, sarcoma, bile duct cancer, cancer of the urinary bladder, kidney cancer, colon cancer, placental choriocarcinoma, cervical cancer, testicular cancer, and uterine cancer. His inventions aim to provide effective treatment options for patients suffering from these serious conditions.

Career Highlights

Michael has worked with notable institutions such as Johannes Gutenberg University Mainz and Ganymed Pharmaceuticals AG. His experience in these organizations has allowed him to advance his research and contribute to the development of groundbreaking cancer therapies.

Collaborations

Michael has collaborated with esteemed colleagues, including Ugur Sahin and Michael Koslowski. These partnerships have further enriched his research and innovation in the field of cancer treatment.

Conclusion

Michael Erdeljan is a dedicated inventor whose work in cancer therapeutics has the potential to impact many lives. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…